Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
Tickers AGIO AMYT ATXI CTIC
Tags GILD ATXI CTIC
From Benzinga
3 Biotech Stocks That Could Boom or Bust in Q1
Tickers OCGN REGN VRTX
Tags Hot Stocks Market News NASDAQ:VRTX,NASDAQ:REGN,NASDAQ:OCGN
From InvestorPlace
5 Things To Expect This Week
Tickers AAPL AMD AMZN APPS
Tags HAL FB OXY
From InvestorPlace
Analyst Ratings For Regeneron Pharmaceuticals
Tickers REGN
Tags Analyst Ratings Market News Benzinga
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Tickers ABBV ABMD AMLX ARWR
Tags GILD JNJ MRK
From Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
Tickers REGN SNY
Tags General Biotech News
From Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
Tickers CTRA LPX MRNA REGN
Tags SWKS SPX CTRA
From MarketWatch
A Deep Dive Into the Video Game Industry
Tickers AAL AAPL AMZN ATVI
Tags DIS TTWO AAPL
From Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
Tickers ABBV PFE REGN SNY
Tags ABBV Market News PFE
From Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
Tickers REGN SNY
Tags SNY Briefs FDA
From Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Tickers ALXO BGNE BIIB IBB
Tags REGN FDA NRIX
From Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
Tickers BNTX DRG IBB JNJ
Tags REGN BNTX SPX
From MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
Tickers BNTX GSK LLY MRK
Tags GSK MRK LLY
From MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
Tickers AXP BRO IBM JNJ
Tags REGN Markets MSFT
From Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
Tickers GILD LLY MRK PFE
Tags Biotech Pandemic Omicron
From Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
Tickers AZN LLY MRK PFE
Tags Market News LLY PFE
From Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
Tickers REGN SNY
Tags General Biotech News
From Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
Tickers ADMA ASLN BGNE CRDF
Tags Biotech IBRX Benzinga
From Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
Tickers REGN
Tags News REGN FDA
From Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
Tickers MRK MRNA PFE REGN
Tags Recent Press Releases REGN MRK
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
Tickers GSK NVS REGN SNY
Tags Recent Press Releases NVS REGN
From Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
Tickers GSK LLY REGN VIR
Tags Health Care LLY Market News
From Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
Tickers CNTB IMAB LLY PFE
Tags General contributors IMAB
From Benzinga
1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022
Tickers ARKK FUBO REGN TSLA
Tags FUBO REGN Recent Press Releases
From Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
Tickers EOG JPM REGN
Tags why it's moving EOG REGN
From Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
Tickers PFE REGN
Tags Geoff Meacham Downgrades Analyst Color
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
Tickers ACAD ADBE ADTH AEL
Tags FERG PRU OXY
From Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
Tickers ALGN NTLA REGN SAVA
Tags ALGN Market News NTLA
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
Tickers ACC ADTH ALNY AVB
Tags GMAB Intraday Update SLG
From Benzinga
Better Buy: CRISPR vs. Intellia
Tickers BLUE CRSP NTLA REGN
Tags Recent Press Releases VRTX REGN
From Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.